{
    "id": 32578,
    "fullName": "MET S997*",
    "impact": "nonsense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "MET S997* results in a premature truncation of the Met protein at amino acid 997 of 1390 (UniProt.org). Due to the loss of the protein kinase domain (UniProt.org), S997* is predicted to lead to a loss of Met protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4233,
        "geneSymbol": "MET",
        "terms": [
            "MET",
            "AUTS9",
            "c-Met",
            "DFNB97",
            "HGFR",
            "RCCP2"
        ]
    },
    "variant": "S997*",
    "createDate": "02/12/2020",
    "updateDate": "02/12/2020",
    "referenceTranscriptCoordinates": {
        "id": 187922,
        "transcript": "NM_000245",
        "gDna": "chr7:g.116771951C>A",
        "cDna": "c.2990C>A",
        "protein": "p.S997*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20338,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, a patient with non-small cell lung cancer treated with Xalkori (crizotinib) demonstrated resistance and plasma testing revealed MET D1010H, MET S997*, MET H1094Y (also referred to as H1112Y), and MET L1195V (PMID: 32034073).",
            "molecularProfile": {
                "id": 35129,
                "profileName": "MET S997* MET D1010H MET H1112Y MET L1195V"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17807,
                    "pubMedId": 32034073,
                    "title": "Molecular mechanisms of acquired resistance to MET tyrosine kinase inhibitors in patients with MET exon 14 mutant NSCLC.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/32034073"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35128,
            "profileName": "MET S997*",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35129,
            "profileName": "MET S997* MET D1010H MET H1112Y MET L1195V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 187922,
            "transcript": "NM_000245",
            "gDna": "chr7:g.116771951C>A",
            "cDna": "c.2990C>A",
            "protein": "p.S997*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}